Kathryn Scharbach MD
Hospice & Palliative Medicine
Assistant Professor, Pediatrics Icahn School of Medicine at Mount Sinai
Join to view full profile
1468 Madison AveNew York, NY 10029
Phone+1 212-241-4901
Dr. Scharbach is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kathryn Scharbach is a pediatrician based in New York, NY, with a subspecialty in Hospice & Palliative Medicine. She completed her residency and chief residency in Pediatrics at Montefiore Medical Center/Albert Einstein College of Medicine. Since 2018, she has been serving as an Assistant Professor at the Pediatric Department of Mount Sinai. Dr. Scharbach has contributed to several publications on topics related to pediatric palliative care and medical complexity in children. She is also a Fellow of the American Academy of Pediatrics (FAAP).
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineChief Residency, Pediatrics, 2007 - 2008- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2004 - 2007
Albert Einstein College of MedicineClass of 2004
Certifications & Licensure
null, NY 2008 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Hospice and Palliative Medicine
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 12 citationsA Multidisciplinary Home Visiting Program for Children With Medical ComplexityElaine Lin, Kathryn Scharbach, Bian Liu, Maureen Braun, Candace Tannis
Hospital Pediatrics. 2020-11-01 - 16 citationsPediatric Palliative Care.Sarah Norris, Sheera Minkowitz, Kathryn Scharbach
Primary Care. 2019-09-01 - 34 citationsIntranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.Daniel M. Fein, Jeffrey R. Avner, Kathryn Scharbach, Deepa Manwani, Hnin Khine
Pediatric Blood & Cancer. 2017-06-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
